Evidence map›Paper›PMID 42626995›Full record

ReviewChembiochem : a European journal of chemical biology2026

Cyclic Thiosulfinates: Synthesis and Applications in Chemical Biology and Materials Science.

Benjamin Liebson, Jeffrey N Agar, Roman Manetsch, Prakash T Parvatkar

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benjamin LiebsonDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0009-0004-4871-0359
Jeffrey N AgarDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-2645-1873
Roman ManetschDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-7038-6867
Prakash T ParvatkarDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-9695-767X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic thiosulfinates (CTs) constitute a distinct class of organosulfur compounds characterized by a polarized ─S(═O)─S─ motif and inherent ring strain, which together dictate their unique reactivity toward thiols. Recent advances in synthetic methodologies, particularly the controlled oxidation of cyclic disulfides, have enabled access to stable CTs with tunable ring sizes and substitution patterns. Mechanistic studies reveal that ring-induced hyperconjugation and conformational constraints enhance nucleophilic substitution, allowing for selective cross-linking of proximal thiols while minimizing the modification of isolated thiols. These properties have positioned CTs as valuable tools in chemical biology for selective thiol targeting and protein cross-linking in complex biological environments. Concurrently, CTs are gaining prominence as dynamic covalent cross-linkers in materials science. This review highlights recent progress in the synthesis, reactivity, and applications of CTs across chemical biology and materials science.

Indexed as

Materials ScienceSulfinic AcidsDisulfidesHumansOxidation-ReductionSulfhydryl CompoundsDisulfidesSulfhydryl CompoundsSulfinic Acidschemical probeoxidationpolymer networksprotein modificationredox biologysulfur heterocycletherapeutics

Identifiers

PMID42626995
PMCPMC13495126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.